Skip to main content

7 July 2025

Last updated: Sunday 6 July 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

A good beginning in the perilous biotech business

Tuesday 26 October 2010

Interviewee/Contributor

Ingmar Hoerr

Organisation

CureVac GmbH

Organisations

Merck Sharp & Dohme (Europe)
NEO New Oncology AG
MedNous contributing editor
Keck School of Medicine, University of Southern California
Sphere Fluidics Ltd
Index Ventures Management LLP
Hansa Medical AB
Synpromics Ltd
TrakCel Ltd
Marks & Clerk LLP

Interviewees and Contributers

Robert Burns
Geert Walther Nygaard
Matthias Kramer
Peter Arlett
Simon Moroney
Clare Ozawa
Morten Grunnet
Jane Buus Laursen
Angelika Joos
Jean-Philippe Tripet

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Louise Peacock joins Aravax

Saturday 5 July 2025

Hans Menssen joins Priothera

Saturday 5 July 2025

Filippa Stenberg joins Mölnlycke Health Care

Saturday 5 July 2025

Commit Biologics appoints scientific advisory board

Saturday 5 July 2025

Cristina Csimma joins Asgard Therapeutics

Saturday 5 July 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form